Trends in Drug
Benefit Design
The 2023 PSG report sponsored by RxSS
Plan sponsors face complex decisions and challenges as they build and implement their drug benefit. Pharmaceutical Strategies Group’s report—sponsored by Rx Savings Solutions—includes insights from 180 benefits leaders representing plans across the country.
Download the report to see how plans are building their Rx benefit.
5 KEY TRENDS
Here’s a snapshot of responses from the report’s survey participants.
Download the full report for the complete picture.
WEIGHT LOSS MEDICATIONS
cover FDA-approved weight loss medications
0
%
may cover these medications in the next 1 to 2 years
0
%
UTILIZATION MANAGEMENT PROGRAMS
A growing percentage of respondents cite cost and cumbersomeness as barriers to utilization management program
GENE THERAPY FINANCIAL PROTECTION PRODUCTS
use a gene therapy financial protection product
0
%
may use these products in the next 1 to 2 years
0
%
FORMULARY MANAGEMENT
0
%
take steps to identify and reduce wasteful spend in the formulary
COST-SHARING
promote cost-sharing transparency tools to help members manage expenses
0
%
are considering changes to their cost-sharing arrangements
0
%
Respondents are individuals who represent employers, unions/Taft-Hartley plans, and health plans and who reported being responsible for managing their organization’s pharmacy benefit. Plans represented in the survey responses ranged in size from less than 50 members to over 10 million members.
